RAPGEFL1
Rap guanine nucleotide exchange factor-like 1
Also known as: Link-GEFII, RPGFL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UHV5
- Gene
- RAPGEFL1
- Ensembl
- ENSG00000108352
- Chromosome
- 17
- Canonical length
- 662 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Microtubules,Cytokinetic bridge
OverviewNCBI Gene
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in Ras protein signal transduction. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
662 residues, UniProt reviewed canonical sequence.
>Q9UHV5|RAPGEFL1
1 MKPLEKFLKK QTSQLAGRTV AGGPGGGLGS CGGPGGGGGP GGGGGPAGGQ RSLQRRQSVS
61 RLLLPAFLRE PPAEPGLEPP VPEEGGEPAG VAEEPGSGGP CWLQLEEVPG PGPLGGGGPL
121 RSPSSYSSDE LSPGEPLTSP PWAPLGAPER PEHLLNRVLE RLAGGATRDS AASDILLDDI
181 VLTHSLFLPT EKFLQELHQY FVRAGGMEGP EGLGRKQACL AMLLHFLDTY QGLLQEEEGA
241 GHIIKDLYLL IMKDESLYQG LREDTLRLHQ LVETVELKIP EENQPPSKQV KPLFRHFRRI
301 DSCLQTRVAF RGSDEIFCRV YMPDHSYVTI RSRLSASVQD ILGSVTEKLQ YSEEPAGRED
361 SLILVAVSSS GEKVLLQPTE DCVFTALGIN SHLFACTRDS YEALVPLPEE IQVSPGDTEI
421 HRVEPEDVAN HLTAFHWELF RCVHELEFVD YVFHGERGRR ETANLELLLQ RCSEVTHWVA
481 TEVLLCEAPG KRAQLLKKFI KIAALCKQNQ DLLSFYAVVM GLDNAAVSRL RLTWEKLPGK
541 FKNLFRKFEN LTDPCRNHKS YREVISKMKP PVIPFVPLIL KDLTFLHEGS KTLVDGLVNI
601 EKLHSVAEKV RTIRKYRSRP LCLDMEASPN HLQTKAYVRQ FQVIDNQNLL FELSYKLEAN
661 SQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAPGEFL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 232 nTPM
Expression across tissuesHPA
Tissue
- skin: 232 nTPM
- esophagus: 195 nTPM
- vagina: 110 nTPM
- cervix: 75 nTPM
- cerebral cortex: 60 nTPM
- colon: 52 nTPM
Single-cell type
- esophageal suprabasal cells: 254 nCPM
- esophageal apical cells: 249 nCPM
- prostatic hillock cells: 239 nCPM
- suprabasal keratinocytes: 198 nCPM
- ocular epithelial cells: 149 nCPM
- respiratory basal cells: 122 nCPM
Immune cell
- neutrophil: 0.5 nTPM
- gdT-cell: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 138 nTPM
- hippocampal formation: 131 nTPM
- amygdala: 96 nTPM
- basal ganglia: 89 nTPM
- white matter: 78 nTPM
- hypothalamus: 48 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.3
- gnomAD missense Z
- 1.76
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- nervous system development
- Ras protein signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAPGEFL1 as an antibody target. Whether an autoantibody or antibody against RAPGEFL1 could matter depends on whether native RAPGEFL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAPGEFL1 is annotated at the cell surface, where native RAPGEFL1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RAPGEFL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...